Prediction of left ventricular functional recovery by dobutamine echocardiography, F-18 deoxyglucose or 99mTc sestamibi nuclear imaging in patients with chronic myocardial infarction

Cardiology

Volumn 98, Issue 4, 2002, Pages 202-209

  Lund, Gunnar K ^a   Freyhoff, Jörg ^a   Schwaiger, Markus ^b   Lübeck, Martin ^a   Lund, Christian H ^a   Buchert, Ralph ^a   Sheehan, Florence H ^c   Meinertz, Thomas ^a   Nienaber, Christoph A ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^c UNIVERSITY OF WASHINGTON   (United States)

Author keywords

99mTc sestamibi; Chronic myocardial dysfunction; Dobutamine echocardiography; F 18 deoxyglucose; Positron emission tomography; Receiver operating characteristic curve analysis; Single photon emission computed tomography; Viability testing

Indexed keywords

DOBUTAMINE; FLUORODEOXYGLUCOSE F 18; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; GLUCOSE METABOLISM; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE REVASCULARIZATION; HEART PERFUSION; HUMAN; MALE; POSITRON EMISSION TOMOGRAPHY; PREDICTION; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

AGED; ECHOCARDIOGRAPHY, STRESS; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL CONTRACTION; MYOCARDIAL INFARCTION; MYOCARDIAL REVASCULARIZATION; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RADIOPHARMACEUTICALS; RECOVERY OF FUNCTION; REPRODUCIBILITY OF RESULTS; ROC CURVE; SENSITIVITY AND SPECIFICITY; TECHNETIUM TC 99M SESTAMIBI; TOMOGRAPHY, EMISSION-COMPUTED; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; VENTRICULAR DYSFUNCTION, LEFT;

EID: 0036957696     PISSN: 00086312     EISSN: None     Source Type: Journal    
DOI: 10.1159/000067311     Document Type: Article

References (25)

1. Bonow RO: Identification of viable myocardium. Circulation 1996;94:2674-2680.
2. Dilsizian V, Bonow RO: Current diagnostic techniques of assessing myocardial viability in patients with hibernating and stunned myocardium. Circulation 1993;87:1-20.
3. Tillisch J, Brunken R, Marshall R, Schwaiger M, Mandelkern M, Phelps M, Schelbert H: Reversibility of cardiac wall-motion abnormalities predicted by positron tomography. N Engl J Med 1986;314:884-888.
4. Nienaber CA, Brunken RC, Sherman CT, Yeatman LA, Gambhir SS, Krivokapich J, Demer LL, Ratib O, Child JS, Phelps ME, et al: Metabolic and functional recovery of ischemic human myocardium after coronary angioplasty. J Am Coll Cardiol 1991;18:966-978.
5. Vanoverschelde J-LJ, Wijns W, Depré C, Essamri B, Heyndrickx G, Borgers M, Bol A, Melin JA: Mechanisms of chronic regional post-ischemic dysfunction in humans: New insights from the study of non-infarcted collateral-dependent myocardium. Circulation 1993;87:1513-1523.
6. Gerber BL, Vanoverschelde J-LJ, Bol A, Michel C, Labar D, Wijns W, Melin JA: Myocardial blood flow, glucose uptake, and recruitment of inotropic reserve in chronic left ventricular ischemic dysfunction. Implications for the pathophysiology of chronic myocardial hibernation. Circulation 1996;94:651-659.
7. Marinho NV, Keogh BE, Costa DC, Lammerstma AA, Ell PJ, Camici PG: Pathophysiology of chronic left ventricular dysfunction. New insights from the measurement of absolute myocardial blood flow and glucose utilization. Circulation 1996;93:737-744.
8. Maes AF, Borgers M, Flameng W, Nuyts JL, Van de Werf F, Ausma JJ, Sergeant P, Mortelmans LA: Assessment of myocardial viability in chronic coronary artery disease using technetium-99m sestamibi SPECT. Correlation with histologic and positron emission tomographic studies and functional follow-up. J Am Coll Cardiol 1997;29:62-68.
9. 99mTc sestamibi SPECT. J Nucl Cardiol 1998;5:4-13.
10. Sheehan FH, Bolson EL, Dodge HT, Mathey DG, Schofer J, Woo HW: Advantages and applications of the centerline method for characterizing regional ventricular function. Circulation 1986;74:293-305.
11. vom Dahl J, Altehoefer C, Sheehan FH, Buechin P, Uebis R, Messmer BJ, Buell U, Hanrath P: Recovery of regional left ventricular dysfunction after coronary revascularization. Impact of myocardial viability assessed by nuclear imaging and vessel patency at follow-up angiography. J Am Coll Cardiol 1996;28:948-958.
12. Rentrop KP, Feit F, Sherman W, Thornton JC: Serial angiographic assessment of coronary artery obstruction and collateral flow in acute myocardial infarction. Report from the second Mount Sinai-New York University Reperfusion Trial. Circulation 1989;80:1166-1175.
13. Stiel GM, Barth K, Eicker B, Vogel C, Towara U, Nienaber CA: AWOS™: Angiographic Workstation for Digital Quantitative Coronary Angiography. Los Alamitos, IEEE Computer Society Press, 1993.
14. Smart SC, Sawada S, Ryan T, Segar D, Atherton L, Berkovitz K, Bourdillon PD, Feigenbaum H: Low-dose dobutamine echocardiography detects reversible dysfunction after thrombolytic therapy of acute myocardial infarction. Circulation 1993;88:405-415.
15. Nekolla SG, Miethaner C, Nguyen N, Ziegler SI, Schwaiger M: Reproducibility of polar map generation and assessment of defect severity and extent assessment in myocardial perfusion imaging using positron emission tomography. Eur J Nucl Med 1998;25:1313-1321.
16. Duvernoy CS, vom Dahl J, Laubenbacher C, Schwaiger M: The role of nitrogen 13 ammonia positron emission tomography in predicting functional outcome after coronary revascularization. J Nucl Cardiol 1995;2:499-506.
17. Hagen MD: Test characteristics. How good is that test? Prim Care 1995;22:213-233.
18. Afridi I, Qureshi U, Kopelen HA, Winters WL, Zoghbi WA: Serial changes in response of hibernating myocardium to inotropic stimulation after revascularization: A dobutamine echocardiographic study. J Am Coll Cardiol 1997;30:1233-1240.
19. Elhendy A, Cornel JH, Roelandt JR, Nierop PR, van Domburg RT, Geleijnse ML, Trocino G, Bax JJ, Ibrahim MM, Fioretti PM: Impact of severity of coronary artery stenosis and the collateral circulation on the functional outcome of dyssynergic myocardium after revascularization in patients with healed myocardial infarction and chronic left ventricular dysfunction. Am J Cardiol 1997;79:883-888.
20. 99mTc-sestamibi. Circulation 1994;89:2552-2561.
21. Pagano D, Bonser RS, Townend JN, Ordoubadi F, Lorenzoni R, Camici PG: Predictive value of dobutamine echocardiography and positron emission tomography in identifying hibernating myocardium in patients with post-ischaemic heart failure. Heart 1998;79:281-288.
22. Salustri A, Elhendy A, Garyfallydis P, Ciavatti M, Cornel JH, ten Cate FJ, Boersma E, Gemelli A, Roelandt JR, Fioretti PM: Prediction of improvement of ventricular function after first acute myocardial infarction using low-dose dobutamine stress echocardiography. Am J Cardiol 1994;74:853-856.
23. Bolognese L, Buonamici P, Cerisano G, Santini A, Carrabba N, Santoro GM, Antoniucci D, Fazzini PF: Early dobutamine echocardiography predicts improvement in regional and global left ventricular function after reperfused acute myocardial infarction without residual stenosis of the infarct-related artery. Am Heart J 2000;139:153-163.
24. Maurea S, Cuocolo A, Soricelli A, Castelli L, Squame F, Imbriaco M, De Luca N, Trimarco B, Salvatore M: Myocardial viability index in chronic coronary artery disease: Technetium-99m-methoxy isobutyl isonitrile redistribution. J Nucl Med 1995;36:1953-1960.
25. 18F-fluorodeoxyglucose. J Am Coll Cardiol 1998;32:927-935.